Biocon Ltd.

Pharmaceuticals & Drugs
Coming Soon
259.10
Price at 10:31 AM

Performance

Biocon Ltd.

Open Price₹257.60
Today's High₹262.90
52W High₹341.50
Deliverables2.97%
Prev. Close₹259.55
Today's Low₹255.95
52W Low₹211.30
Volume114624

Fundamentals

Market Cap
₹31,146 Cr
EPS(TTM)
₹8.27
Book Value
₹54.63
Face Value
₹5.00
Industry P/E
16.39
P/E
17.20
P/B
4.75
Div. Yield
0.19%

About the Company

Biocon Ltd. is in Pharmaceuticals & Drugs. It was incorporated in year 1978. The current market capitalisation stands Rs 31146 Cr. The company is listed on the Bombay Stock Exchange (BSE) with the BSE code as 532523. and also listed on National Stock Exchange (NSE) with NSE code as BIOCON.
Biocon Limited, a biopharmaceutical company, develops, manufactures, and sells biopharmaceuticals for diabetes, cancer, and autoimmune conditions. It operates through Small Molecule APIs and Generic Formulations, Biologics, Branded Formulations, and Research Services segments. The provides biosimilars comprising recombinant human insulin, insulin glargine, insulin lispro, insulin aspart, and monoclonal antibodies and other biologics; small molecules; and provides branded formulation products under the Insugen, Basalog, BIOMAb EGFR, CANMAb, and ALZUMAb brands. In addition, it is involved in the integrated discovery, development, and manufacturing services for novel molecules, including small molecules, large molecules, antibody-drug conjugates, and oligonucleotides. Further, the offers botanical products. It serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.
... Read More
Organisation
Biocon
Founded Year
1978
Managing Director
Kiran Mazumdar-Shaw

Market Updates

News
Events
Not available currently
ⓒ 2019 Billionbrains Garage Ventures Pvt Ltd